But unlike in T1DM mice, EcN-GLP-1 treatment also resulted in an increase in Clostridium IV (p < 0.01) and a decrease in Alistipes and Rikenella (p < 0.05) (Figure 6(g) and Supporting Figure 1b). The gene discussed is GLP1R; the disease is type 1 diabetes mellitus.